108 related articles for article (PubMed ID: 11009270)
21. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.
Tsutamoto T; Wada A; Sakai H; Ishikawa C; Tanaka T; Hayashi M; Fujii M; Yamamoto T; Dohke T; Ohnishi M; Takashima H; Kinoshita M; Horie M
J Am Coll Cardiol; 2006 Feb; 47(3):582-6. PubMed ID: 16458140
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy.
Stangl K; Dschietzig T; Richter C; Laule M; Stangl V; Tanis E; Baumann G; Felix SB
Circulation; 2000 Sep; 102(10):1132-8. PubMed ID: 10973842
[TBL] [Abstract][Full Text] [Related]
24. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
[TBL] [Abstract][Full Text] [Related]
25. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Ishii C
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S19-22. PubMed ID: 12688391
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure.
Tsutamoto T; Hisanaga T; Fukai D; Wada A; Maeda Y; Maeda K; Kinoshita M
Am J Cardiol; 1995 Oct; 76(11):803-8. PubMed ID: 7572659
[TBL] [Abstract][Full Text] [Related]
27. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
Hayashi M
J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
[TBL] [Abstract][Full Text] [Related]
28. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary endothelinergic system in experimental congestive heart failure.
Lepailleur-Enouf D; Egidy G; Philippe M; Louedec L; Henry J; Mulder P; Michel J
Cardiovasc Res; 2001 Feb; 49(2):330-9. PubMed ID: 11164843
[TBL] [Abstract][Full Text] [Related]
30. Association between plasma endothelin-1 levels and Cheyne-Stokes respiration in patients with congestive heart failure.
El-Solh AA; Bozkanat E; Mador J; Grant BJ
Chest; 2002 Jun; 121(6):1928-34. PubMed ID: 12065359
[TBL] [Abstract][Full Text] [Related]
31. [Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients].
Rivera M; Cortés R; Portolés M; Valero R; Sancho-Tello MJ; Martínez-Dolz L; Sevilla B; Taléns-Visconti R; Jordán A; Miró V; Pérez-Boscá JL; Marín F; Climent V; García de Burgos F; Payá R; Sogorb F; Bertomeu V; Salvador A
Rev Esp Cardiol; 2005 Mar; 58(3):278-84. PubMed ID: 15766450
[TBL] [Abstract][Full Text] [Related]
32. [Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Salomon P; Przewłocka-Kosmala M; Orda A
Pol Arch Med Wewn; 2003 Jan; 109(1):43-8. PubMed ID: 12879765
[TBL] [Abstract][Full Text] [Related]
33. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
Kaye DM; Khammy O; Mariani J; Maeder MT
Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
[TBL] [Abstract][Full Text] [Related]
34. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.
Krum H; Denver R; Tzanidis A; Martin P
Heart Fail Rev; 2001 Dec; 6(4):341-52. PubMed ID: 11447309
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1.
von Lueder TG; Kjekshus H; Edvardsen T; ØIe E; Urheim S; Vinge LE; Ahmed MS; Smiseth OA; Attramadal H
Cardiovasc Res; 2004 Jul; 63(1):41-50. PubMed ID: 15194460
[TBL] [Abstract][Full Text] [Related]
38. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
Oie E; Bjønerheim R; Grogaard HK; Kongshaug H; Smiseth OA; Attramadal H
Am J Physiol; 1998 Sep; 275(3):H868-77. PubMed ID: 9724291
[TBL] [Abstract][Full Text] [Related]
39. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.
Takashio S; Yamamuro M; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Ogawa H
J Am Coll Cardiol; 2013 Aug; 62(7):632-40. PubMed ID: 23644085
[TBL] [Abstract][Full Text] [Related]
40. Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure.
Dupuis J; Moe GW; Cernacek P
Cardiovasc Res; 1998 Sep; 39(3):609-16. PubMed ID: 9861303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
